Developer docs
API playgroundTry for free, no card

Search company profiles

AMI Technologies

Full company profile

uuid000vzh4

Namestring
AMI Technologies
Legal namestring
AMI Medical Technologies Ltd. (אמי טכנולוגיות רפואיות בע״מ)
Websiteurl
ami.co.il
Company typeenum
Private
Founded yearint
1986
Descriptiontext

AMI Technologies is an Israeli-exclusive distributor of advanced medical devices, biopharmaceutical products, and surgical technologies, operating since 1986 as the local representative for leading international manufacturers from Europe and the United States. Headquartered in Hod Hasharon, the company sells to Israeli hospitals (enterprise), medical and aesthetic clinics (mid-market), and individual treatment rooms (SMB), covering clinical specialties that include dermatology and aesthetics, plastic surgery, neurosurgery, orthopedics, urology, cardiology, imaging, ENT, vascular, and women's health. The portfolio spans 24-plus products including laser platforms (Hollywood Spectra, eCO2 3D, MOSAIC 3D, Ultra, DERMA V, Xeo Plus, AviClear), energy-based devices (Tixel, Ultraformer MPT, XERF), injectable biopharmaceuticals (Sculptra, Restylane, Cellbooster, AnteAGE MD, Biosome MDX, Mastelli PLINEST), surgical platforms (vNOTES, Stryker neurosurgery and endoscopy, BK Medical intraoperative ultrasound), and diagnostic devices (Clarius wireless ultrasound, T-Stat tissue oximeter, FemaSeed, FemVue).

The business model is B2B distribution on a quote-based pricing structure, with revenue generated from hardware sales of manufacturer-supplied equipment and consumables to Israeli healthcare providers. The company holds ISO 9001, ISO 27001, and ISO 27799 certifications updated to the 2022 version. Go-to-market is multi-channel: direct sales force coverage of hospitals and clinics, manufacturer-aligned training workshops, on-demand video content for physicians, and a Hebrew/English website (ami.co.il) supported by LinkedIn and Facebook presence. Recent strategic activity (2023-2026) has focused on expanding the regenerative medicine and fertility verticals through new principal partnerships (including Femasys Inc. in April 2026) and broadened product launches. The company is led by CEO Teli Schecter, operates as a privately held Israeli limited company, and has no disclosed ownership changes, institutional investors, or M&A activity.

Ownership structure is private with no publicly disclosed shareholders, venture backing, or private equity involvement. The company is a channel partner for international manufacturers rather than a developer of proprietary technology, and all devices distributed are FDA, CE, and AMAR approved by their respective manufacturers. Recent portfolio momentum includes entry into fertility/women's health (Femasys), regenerative medicine (Biosome MDX exosomes, Mastelli PLINEST polynucleotides), and seven-plus new product launches in 2026 alone.

Short descriptiontext

AMI Technologies is an Israeli-exclusive distributor of advanced medical devices, biopharmaceuticals, and surgical technologies for leading global manufacturers, serving hospitals, clinics, and treatment rooms across multiple specialties since 1986.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersHod Hasharon, Israel
HQ citystring
Hod Hasharon
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device distribution, aesthetic medical equipment, surgical technology, biopharmaceutical products, healthcare distribution
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Device Distribution
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Distribution
TypeHardware Sales
Description

Distribution of medical devices and technologies to healthcare providers including hospitals, clinics, and treatment rooms. Revenue generated through sales of equipment from international manufacturer partners.

ami.co.il
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Medical device pricing varies by product category and customer type
ModelOtherBilling cadenceOther
Notes

Quote-based pricing; product categories include surgical equipment, aesthetic devices, diagnostic tools, and medical supplies

ami.co.il
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

AMI Technologies is the exclusive Israeli distributor for leading international medical technology manufacturers, marketing and selling advanced medical devices, biopharmaceutical products and surgical systems to hospitals, clinics and private treatment rooms. The company supplies a multi-specialty portfolio spanning dermatology/aesthetics, regenerative medicine, plastic surgery, neurosurgery, orthopedics, urology, cardiology and imaging, and provides accompanying training, implementation and after-sales support.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

AMI Technologies is a leading Israeli medical technology distributor offering a comprehensive portfolio of medical devices, biopharmaceutical products, and surgical technologies across multiple specialties including dermatology/aesthetics, regenerative medicine, plastic surgery, neurosurgery, orthopedics, urology, cardiology, and imaging. The portfolio includes laser platforms (Hollywood Spectra, eCO2, MOSAIC 3D, Ultra, DERMA V, Xeo Plus, AviClear), energy-based devices (Tixel, Ultraformer MPT, XERF), injectable biopharmaceuticals (Sculptra, Restylane, Cellbooster, AnteAGE MD, Biosome MDX, Mastelli PLINEST), surgical systems (vNOTES/Gel Point, Stryker instruments, BK Medical ultrasound), and diagnostic/monitoring devices (Clarius, T-Stat, FemaSeed, FemVue). The company operates as an exclusive distributor for major international manufacturers including Stryker, Galderma, Lutronic, Cutera, and others, providing both products and comprehensive service support to healthcare providers in Israel.

Product and service18 records
1Tixel
CategoryMedical Device - Aesthetic Energy-Based
Description

Thermal fractional system for skin rejuvenation, anti-aging treatments, and aesthetic indications including wrinkles, acne scars, and skin texture improvement, sold to dermatologists and aesthetic clinics.

2Ultraformer MPT
CategoryMedical Device - Aesthetic Energy-Based
Description

Advanced HIFU (High-Intensity Focused Ultrasound) device for non-invasive lifting, skin tightening, and body contouring treatments, marketed to aesthetic clinics and plastic surgery practices.

3Cellbooster
CategoryBiopharmaceutical Product - Injectable
Description

Stabilized booster complex for injection based on non-cross-linked hyaluronic acid with active ingredients using CHAC technology for delayed release, marketed to dermatologists and aesthetic physicians.

4AnteAGE MD
CategoryBiopharmaceutical Product - Regenerative
Description

Product line based on cytokines and growth factors for various dermatological and aesthetic indications, combined with medical devices, marketed to aesthetic physicians.

5Biosome MDX
CategoryBiopharmaceutical Product - Regenerative
Description

Synthetic exosome product for enhancing tissue regenerative capacity, containing concentrated proteins and growth factors for dermatological indications, marketed to aesthetic physicians.

6Sculptra
CategoryBiopharmaceutical Product - Injectable
Description

Collagen biostimulator containing poly-L-lactic acid microparticles that stimulates natural collagen production for skin quality improvement, marketed to aesthetic and dermatology practices.

7Restylane
CategoryMedical Device - Dermal Filler
Description

Hyaluronic acid dermal fillers for facial contouring, sculpting and enhancement using NASHA and OBT technologies, marketed to aesthetic clinics and plastic surgeons.

8Restylane Skinboosters
CategoryMedical Device - Skin Quality Injectable
Description

Stabilized hyaluronic acid for skin quality improvement, providing deep hydration and improving skin texture and radiance, marketed to aesthetic physicians.

9Clarius
CategoryMedical Device - Diagnostic Imaging
Description

Wireless handheld ultrasound scanner with 20MHz frequency for high-quality imaging in aesthetic and surgical procedures, marketed to plastic surgeons and aesthetic clinics.

10T-Stat
CategoryMedical Device - Patient Monitoring
Description

VLS Tissue Oximeter using White Light Technology for continuous, non-invasive tissue monitoring, marketed to surgical and aesthetic practices.

11Hollywood Spectra
CategoryMedical Device - Aesthetic Laser
Description

Q-Switched Nd:YAG laser platform with Hollywood Laser Peel for skin rejuvenation, tattoo removal and pigment treatments, marketed to aesthetic clinics.

12SkinPen Elite
CategoryMedical Device - Aesthetic Energy-Based
Description

Medical-grade microneedling device for skin rejuvenation, scar treatment, and collagen induction therapy, marketed to dermatologists and aesthetic practices.

13LipoDefine
CategoryMedical Device - Body Contouring Laser
Description

Minimal invasive laser technology using 1470nm or 980nm wavelengths for fat dissolution and skin tightening, marketed to plastic surgeons and aesthetic clinics.

14XERF
CategoryMedical Device - Aesthetic Energy-Based
Description

Dual-frequency RF platform combining 6.78MHz and 2MHz for non-invasive skin lifting, tightening and tissue remodeling, marketed to aesthetic practices.

15AviClear
CategoryMedical Device - Aesthetic Laser
Description

Laser platform using 1726nm wavelength for long-term acne treatment by targeting sebaceous glands, marketed to dermatologists.

16MOSAIC 3D
CategoryMedical Device - Aesthetic Laser
Description

Non-ablative fractional laser platform using 3D Controlled Chaos Technology at 1550nm for wrinkle, scar, and skin texture treatments, marketed to aesthetic clinics.

17Ultra
CategoryMedical Device - Aesthetic Laser
Description

Thulium 1927nm fractional laser with Magnetic Roller Tracking for skin rejuvenation and pigment treatment, marketed to aesthetic practices.

18DERMA V
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-16
Description

Femasys Inc. partnered with AMI Technologies to commercialize its FemaSeed artificial insemination device and FemVue diagnostic tool in Israel. AMI Technologies handles distribution and commercialization through its existing healthcare provider network. FemaSeed has regulatory approvals in multiple markets including US, Europe, and UK, and achieved pregnancy rates more than double those of standard intrauterine insemination in clinical trials.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Medline Industries
TypeBroad incumbent
Description

Largest privately held medical supply manufacturer and distributor in the US, offering medical-surgical products to hospitals and healthcare facilities. Comparable as a private specialty medical distributor with manufacturer partnerships.

TypeBroad incumbent
Description

One of the largest healthcare distribution companies globally, distributing medical and surgical products to hospitals, pharmacies, and physician offices. Operates at much larger scale but exemplifies the broad incumbent medical distribution model.

TypeRegional player
Description

Israeli medical device and pharmaceutical distributor representing international manufacturers in Israel. Comparable as a regional specialty medical distributor with similar exclusive distribution agreements and Israeli market focus.

TypeBroad incumbent
Description

Global Fortune 500 medical and dental products distributor serving healthcare providers worldwide. Comparable as the largest medical device distribution platform, though far larger and broader than AMI's Israel-exclusive specialty focus.

TypeBroad incumbent
Description

Leading medical-surgical supply distributor serving more than 250,000 US healthcare customers. Comparable medical device and supply distribution model with extensive manufacturer relationships.

6Patterson Companies
TypeBroad incumbent
Description

US-focused medical and dental distributor with similar value-added services model (sales, equipment, technology solutions) to healthcare providers. Comparable as a specialty medical distributor with manufacturer representation relationships, though focused on US/Canada.

7Medison Group
TypeRegional player
Description

Israeli specialty pharmaceutical and medical device distribution company with exclusive representation of international manufacturers. Comparable as a regional player with exclusive distribution model and similar Israel-market focus.

TypeBroad incumbent
Description

German medical device and pharmaceutical company with direct distribution to hospitals worldwide. Comparable as a manufacturer-distributor model serving Israeli healthcare (B. Braun has Israel operations) with multi-specialty medical device portfolios.

TypeOthers
Description

One of AMI's largest manufacturer partners; global medical device giant with direct Israel operations. Relevant as a key supplier whose relationship dynamics are central to AMI's business risk profile, though not a true peer (manufacturer, not distributor).

TypeBroad incumbent
Description

Major medical/surgical product distribution and healthcare supply chain company. Comparable business model of distributing medical products to hospitals and healthcare providers with value-added services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AMI Technologies

Medical Device Distributionami.co.il

AMI Technologies is an Israeli-exclusive distributor of advanced medical devices, biopharmaceuticals, and surgical technologies for leading global manufacturers, serving hospitals, clinics, and treatment rooms across multiple specialties since 1986.

What AMI Technologies does

AMI Technologies is an Israeli-exclusive distributor of advanced medical devices, biopharmaceutical products, and surgical technologies, operating since 1986 as the local representative for leading international manufacturers from Europe and the United States. Headquartered in Hod Hasharon, the company sells to Israeli hospitals (enterprise), medical and aesthetic clinics (mid-market), and individual treatment rooms (SMB), covering clinical specialties that include dermatology and aesthetics, plastic surgery, neurosurgery, orthopedics, urology, cardiology, imaging, ENT, vascular, and women's health. The portfolio spans 24-plus products including laser platforms (Hollywood Spectra, eCO2 3D, MOSAIC 3D, Ultra, DERMA V, Xeo Plus, AviClear), energy-based devices (Tixel, Ultraformer MPT, XERF), injectable biopharmaceuticals (Sculptra, Restylane, Cellbooster, AnteAGE MD, Biosome MDX, Mastelli PLINEST), surgical platforms (vNOTES, Stryker neurosurgery and endoscopy, BK Medical intraoperative ultrasound), and diagnostic devices (Clarius wireless ultrasound, T-Stat tissue oximeter, FemaSeed, FemVue).

The business model is B2B distribution on a quote-based pricing structure, with revenue generated from hardware sales of manufacturer-supplied equipment and consumables to Israeli healthcare providers. The company holds ISO 9001, ISO 27001, and ISO 27799 certifications updated to the 2022 version. Go-to-market is multi-channel: direct sales force coverage of hospitals and clinics, manufacturer-aligned training workshops, on-demand video content for physicians, and a Hebrew/English website (ami.co.il) supported by LinkedIn and Facebook presence. Recent strategic activity (2023-2026) has focused on expanding the regenerative medicine and fertility verticals through new principal partnerships (including Femasys Inc. in April 2026) and broadened product launches. The company is led by CEO Teli Schecter, operates as a privately held Israeli limited company, and has no disclosed ownership changes, institutional investors, or M&A activity.

Ownership structure is private with no publicly disclosed shareholders, venture backing, or private equity involvement. The company is a channel partner for international manufacturers rather than a developer of proprietary technology, and all devices distributed are FDA, CE, and AMAR approved by their respective manufacturers. Recent portfolio momentum includes entry into fertility/women's health (Femasys), regenerative medicine (Biosome MDX exosomes, Mastelli PLINEST polynucleotides), and seven-plus new product launches in 2026 alone.

AMI Technologies firmographics

Firmographics
Name
AMI Technologies
Legal name
AMI Medical Technologies Ltd. (אמי טכנולוגיות רפואיות בע״מ)
Website
https://ami.co.il
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
101–250 employees
Short description
AMI Technologies is an Israeli-exclusive distributor of advanced medical devices, biopharmaceuticals, and surgical technologies for leading global manufacturers, serving hospitals, clinics, and treatment rooms across multiple specialties since 1986.
Ownership category
akta.pro rank

Where AMI Technologies is headquartered

Location

Headquarters

HQ city
Hod Hasharon
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

AMI Technologies business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Medical Device Distribution: Distribution of medical devices and technologies to healthcare providers including hospitals, clinics, and treatment rooms. Revenue generated through sales of equipment from international manufacturer partners.

Pricing tiers

ModelBillingPrice
OtherOtherMedical device pricing varies by product category and customer type

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

AMI Technologies product offering

Product offering

Core offering

AMI Technologies is the exclusive Israeli distributor for leading international medical technology manufacturers, marketing and selling advanced medical devices, biopharmaceutical products and surgical systems to hospitals, clinics and private treatment rooms. The company supplies a multi-specialty portfolio spanning dermatology/aesthetics, regenerative medicine, plastic surgery, neurosurgery, orthopedics, urology, cardiology and imaging, and provides accompanying training, implementation and after-sales support.

Product overview

AMI Technologies is a leading Israeli medical technology distributor offering a comprehensive portfolio of medical devices, biopharmaceutical products, and surgical technologies across multiple specialties including dermatology/aesthetics, regenerative medicine, plastic surgery, neurosurgery, orthopedics, urology, cardiology, and imaging. The portfolio includes laser platforms (Hollywood Spectra, eCO2, MOSAIC 3D, Ultra, DERMA V, Xeo Plus, AviClear), energy-based devices (Tixel, Ultraformer MPT, XERF), injectable biopharmaceuticals (Sculptra, Restylane, Cellbooster, AnteAGE MD, Biosome MDX, Mastelli PLINEST), surgical systems (vNOTES/Gel Point, Stryker instruments, BK Medical ultrasound), and diagnostic/monitoring devices (Clarius, T-Stat, FemaSeed, FemVue). The company operates as an exclusive distributor for major international manufacturers including Stryker, Galderma, Lutronic, Cutera, and others, providing both products and comprehensive service support to healthcare providers in Israel.

Differentiator

Problem solved

Functional benefit

Products and services

  • Tixel Thermal fractional system for skin rejuvenation, anti-aging treatments, and aesthetic indications including wrinkles, acne scars, and skin texture improvement, sold to dermatologists and aesthetic clinics.
  • Ultraformer MPT Advanced HIFU (High-Intensity Focused Ultrasound) device for non-invasive lifting, skin tightening, and body contouring treatments, marketed to aesthetic clinics and plastic surgery practices.
  • Cellbooster Stabilized booster complex for injection based on non-cross-linked hyaluronic acid with active ingredients using CHAC technology for delayed release, marketed to dermatologists and aesthetic physicians.
  • AnteAGE MD Product line based on cytokines and growth factors for various dermatological and aesthetic indications, combined with medical devices, marketed to aesthetic physicians.
  • Biosome MDX Synthetic exosome product for enhancing tissue regenerative capacity, containing concentrated proteins and growth factors for dermatological indications, marketed to aesthetic physicians.
  • Sculptra Collagen biostimulator containing poly-L-lactic acid microparticles that stimulates natural collagen production for skin quality improvement, marketed to aesthetic and dermatology practices.
  • Restylane Hyaluronic acid dermal fillers for facial contouring, sculpting and enhancement using NASHA and OBT technologies, marketed to aesthetic clinics and plastic surgeons.
  • Restylane Skinboosters Stabilized hyaluronic acid for skin quality improvement, providing deep hydration and improving skin texture and radiance, marketed to aesthetic physicians.
  • Clarius Wireless handheld ultrasound scanner with 20MHz frequency for high-quality imaging in aesthetic and surgical procedures, marketed to plastic surgeons and aesthetic clinics.
  • T-Stat VLS Tissue Oximeter using White Light Technology for continuous, non-invasive tissue monitoring, marketed to surgical and aesthetic practices.
  • Hollywood Spectra Q-Switched Nd:YAG laser platform with Hollywood Laser Peel for skin rejuvenation, tattoo removal and pigment treatments, marketed to aesthetic clinics.
  • SkinPen Elite Medical-grade microneedling device for skin rejuvenation, scar treatment, and collagen induction therapy, marketed to dermatologists and aesthetic practices.
  • LipoDefine Minimal invasive laser technology using 1470nm or 980nm wavelengths for fat dissolution and skin tightening, marketed to plastic surgeons and aesthetic clinics.
  • XERF Dual-frequency RF platform combining 6.78MHz and 2MHz for non-invasive skin lifting, tightening and tissue remodeling, marketed to aesthetic practices.
  • AviClear Laser platform using 1726nm wavelength for long-term acne treatment by targeting sebaceous glands, marketed to dermatologists.
  • MOSAIC 3D Non-ablative fractional laser platform using 3D Controlled Chaos Technology at 1550nm for wrinkle, scar, and skin texture treatments, marketed to aesthetic clinics.
  • Ultra Thulium 1927nm fractional laser with Magnetic Roller Tracking for skin rejuvenation and pigment treatment, marketed to aesthetic practices.
  • DERMA V

Companies that use AMI Technologies

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

AMI Technologies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

AMI Technologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Femasys Inc.coreChannel Partner/ Reseller/ Distributor · 16 April 2026Femasys Inc. partnered with AMI Technologies to commercialize its FemaSeed artificial insemination device and FemVue diagnostic tool in Israel. AMI Technologies handles distribution and commercialization through its existing healthcare provider network. FemaSeed has regulatory approvals in multiple markets including US, Europe, and UK, and achieved pregnancy rates more than double those of standard intrauterine insemination in clinical trials.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

AMI Technologies competitors and assessment

Company assessment

Broad incumbents

  • Medline Industries: Largest privately held medical supply manufacturer and distributor in the US, offering medical-surgical products to hospitals and healthcare facilities. Comparable as a private specialty medical distributor with manufacturer partnerships.
  • Cardinal Health: One of the largest healthcare distribution companies globally, distributing medical and surgical products to hospitals, pharmacies, and physician offices. Operates at much larger scale but exemplifies the broad incumbent medical distribution model.
  • Henry Schein: Global Fortune 500 medical and dental products distributor serving healthcare providers worldwide. Comparable as the largest medical device distribution platform, though far larger and broader than AMI's Israel-exclusive specialty focus.
  • McKesson Medical-Surgical: Leading medical-surgical supply distributor serving more than 250,000 US healthcare customers. Comparable medical device and supply distribution model with extensive manufacturer relationships.
  • Patterson Companies: US-focused medical and dental distributor with similar value-added services model (sales, equipment, technology solutions) to healthcare providers. Comparable as a specialty medical distributor with manufacturer representation relationships, though focused on US/Canada.
  • B. Braun Medical: German medical device and pharmaceutical company with direct distribution to hospitals worldwide. Comparable as a manufacturer-distributor model serving Israeli healthcare (B. Braun has Israel operations) with multi-specialty medical device portfolios.
  • Owens & Minor: Major medical/surgical product distribution and healthcare supply chain company. Comparable business model of distributing medical products to hospitals and healthcare providers with value-added services.

Regional players

  • Lapidot Group: Israeli medical device and pharmaceutical distributor representing international manufacturers in Israel. Comparable as a regional specialty medical distributor with similar exclusive distribution agreements and Israeli market focus.
  • Medison Group: Israeli specialty pharmaceutical and medical device distribution company with exclusive representation of international manufacturers. Comparable as a regional player with exclusive distribution model and similar Israel-market focus.

Others

  • Stryker (Israel): One of AMI's largest manufacturer partners; global medical device giant with direct Israel operations. Relevant as a key supplier whose relationship dynamics are central to AMI's business risk profile, though not a true peer (manufacturer, not distributor).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

AMI Technologies social profiles

Digital presence

AMI Technologies compliance and trust

Trust signal

Compliance3 records

AMI Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AMI Technologies leadership team

Management profile

Number of profiles

Profiles1 record

AMI Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AMI Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMI Technologies

What does AMI Technologies do?

AMI Technologies is the exclusive Israeli distributor for leading international medical technology manufacturers, marketing and selling advanced medical devices, biopharmaceutical products and surgical systems to hospitals, clinics and private treatment rooms. The company supplies a multi-specialty portfolio spanning dermatology/aesthetics, regenerative medicine, plastic surgery, neurosurgery, orthopedics, urology, cardiology and imaging, and provides accompanying training, implementation and after-sales support.

Is AMI Technologies a public or private company?

AMI Technologies is a private company. It is classified as unknown and is currently operating.

When was AMI Technologies founded?

AMI Technologies was founded in 1986. It employs 101 to 250 people.

Where is AMI Technologies based?

AMI Technologies is headquartered in Hod Hasharon, Israel, in the Middle East region.

How does AMI Technologies make money?

One revenue line is on record: medical Device Distribution.

Who are AMI Technologies's main competitors?

Broad incumbents on record are Medline Industries, Cardinal Health, Henry Schein, McKesson Medical-Surgical, Patterson Companies, B. Braun Medical and Owens & Minor. Regional players are Lapidot Group and Medison Group. Stryker (Israel) is listed as an others.

Does AMI Technologies have an API?

No public API is recorded for AMI Technologies.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageFemasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate UpdateFemasys Inc. reported financial results for the quarter ended June 30, 2026, announcing a $30 million private placement and regained compliance with Nasdaq listing requirements. The company posted a net loss of $4.5 million for the quarter, while sales decreased by 18.9% due to lower FemVue sales. Corporate updates include the launch of FemaSeed Complete at ACOG 2026, CE Mark approval for the FemHSG Catheter, and a strategic partnership with AMI Technologies in Israel.GlobeNewswireFemasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate UpdateFemasys reported Q1 2026 sales of $424,889, up 24.5% year-over-year, and net income of $846,100, reversing a prior-year loss. The company initiated patient enrollment in the FINALE pivotal trial for FemBloc, advancing toward U.S. FDA approval, and expects cash to fund operations into Q3 2026.Investing.comFemasys partners with AMI Technologies for Israel market entry By Investing.comFemasys Inc., a medical device manufacturer focused on fertility treatments, has partnered with AMI Technologies to commercialize its FemaSeed artificial insemination device and FemVue diagnostic tool in Israel. AMI Technologies will handle distribution and commercialization through its existing healthcare provider network, as Femasys reports 41% revenue growth over the trailing twelve months. FemaSeed has regulatory approvals in multiple markets including the US, Europe, and UK, and achieved pregnancy rates more than double those of standard intrauterine insemination in clinical trials.GlobeNewswireFemasys Drives International Growth with Israeli Market Entry for Fertility PortfolioFemasys announced a partnership with AMI Technologies to introduce its fertility portfolio in Israel, including FemaSeed as a first-line infertility treatment and FemVue for tubal diagnosis. The collaboration aims to accelerate adoption across Israeli fertility centers, leveraging AMI's commercial infrastructure.BioSpaceFemasys Drives International Growth with Israeli Market Entry for Fertility PortfolioFemasys announced a partnership with AMI Technologies to introduce its fertility portfolio in Israel, including FemaSeed as a first-line infertility treatment. The collaboration aims to accelerate adoption across Israeli fertility centers, leveraging AMI's commercial infrastructure. FemaSeed has achieved over double the pregnancy rates of IUI in low male sperm count cases.